Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Apr 3;82(9):1553–1556. doi: 10.1054/bjoc.2000.1177

The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation

S A Butler 1, M S Ikram 1, S Mathieu 1, R K Iles 1
PMCID: PMC2363404  PMID: 10789723

Abstract

Ectopic production of free beta human chorionic gonadotrophin (hCGβ) by bladder carcinoma is well described and occurs in approximately 35% of cases. hCGβ secreting tumours are more aggressive, radioresistant and have a greater propensity to metastasize. We proposed that the ectopic production of hCGβ was contributing in an autocrine fashion to the radioresistance and metastatic potential of such secreting tumours. Though we demonstrated that the addition of hCGβ to the culture media of bladder, cervical and endometrial carcinoma cell lines brought about an increase in cell populations this was not accompanied by a significant increase in the rate of replication. Since a cell population size is a balance of mitosis and mortality, we proposed that hCGβ was inhibiting apoptosis. Here we have demonstrated that following incubation with recombinant hCGβ, bladder carcinoma cells refrain from undergoing apoptosis. Quantitation of apoptotic bodies was carried out by immunoassay and corrected to cell number as determined by MTT assay. In each cell line, addition of hCGβ reduced the number of apoptotic bodies dose-dependently, indicating a diminished apoptotic rate. Furthermore, TGFβ1-induced apoptosis could be dose-dependently inhibited by co-incubation with hCGβ. We propose, therefore, that such a decline in apoptosis may account for the cell population increase previously reported. It may also explain the radioresistance and aggressive nature of hCGβ-secreting tumours and the poor prognosis associated therein. © 2000 Cancer Research Campaign

Keywords: free hCGβ, cystine knot growth factor, apoptosis, bladder cancer

Full Text

The Full Text of this article is available as a PDF (78.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Butler S. A., Laidler P., Porter J. R., Kicman A. T., Chard T., Cowan D. A., Iles R. K. The beta-subunit of human chorionic gonadotrophin exists as a homodimer. J Mol Endocrinol. 1999 Apr;22(2):185–192. doi: 10.1677/jme.0.0220185. [DOI] [PubMed] [Google Scholar]
  2. Cole L. A., Wang Y. X., Elliott M., Latif M., Chambers J. T., Chambers S. K., Schwartz P. E. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers. Cancer Res. 1988 Mar 1;48(5):1356–1360. [PubMed] [Google Scholar]
  3. Gillott D. J., Iles R. K., Chard T. The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer. 1996 Feb;73(3):323–326. doi: 10.1038/bjc.1996.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Iles R. K., Butler S. A., Jacoby E. Dimerization of urinary beta-core/hCFbetacf: a cause of poor beta-core assay performance in Down syndrome screening studies. Prenat Diagn. 1999 Aug;19(8):790–792. [PubMed] [Google Scholar]
  5. Iles R. K., Chard T. Immunochemical analysis of the human chorionic gonadotrophin-like material secreted by 'normal' and neoplastic urothelial cells. J Mol Endocrinol. 1989 Mar;2(2):107–112. doi: 10.1677/jme.0.0020107. [DOI] [PubMed] [Google Scholar]
  6. Lapthorn A. J., Harris D. C., Littlejohn A., Lustbader J. W., Canfield R. E., Machin K. J., Morgan F. J., Isaacs N. W. Crystal structure of human chorionic gonadotropin. Nature. 1994 Jun 9;369(6480):455–461. doi: 10.1038/369455a0. [DOI] [PubMed] [Google Scholar]
  7. Lunardi-Iskandar Y., Bryant J. L., Zeman R. A., Lam V. H., Samaniego F., Besnier J. M., Hermans P., Thierry A. R., Gill P., Gallo R. C. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature. 1995 May 4;375(6526):64–68. doi: 10.1038/375064a0. [DOI] [PubMed] [Google Scholar]
  8. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  9. Pierce J. G., Parsons T. F. Glycoprotein hormones: structure and function. Annu Rev Biochem. 1981;50:465–495. doi: 10.1146/annurev.bi.50.070181.002341. [DOI] [PubMed] [Google Scholar]
  10. Sporn M. B., Roberts A. B., Wakefield L. M., Assoian R. K. Transforming growth factor-beta: biological function and chemical structure. Science. 1986 Aug 1;233(4763):532–534. doi: 10.1126/science.3487831. [DOI] [PubMed] [Google Scholar]
  11. Sun P. D., Davies D. R. The cystine-knot growth-factor superfamily. Annu Rev Biophys Biomol Struct. 1995;24:269–291. doi: 10.1146/annurev.bb.24.060195.001413. [DOI] [PubMed] [Google Scholar]
  12. Twentyman P. R., Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer. 1987 Sep;56(3):279–285. doi: 10.1038/bjc.1987.190. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES